Current Clinical Studies
RIM Study
The RIM study (Rituximab in Myositis) is a study for those with Adult and Juvenile Dermatomyositis(DM) and Adult Polymyositis(PM).The purpose of this research study is to evaluate the effectiveness of the study drug, Rituximab, in people diagnosed with Dermatomyositis (DM) a disease that causes muscle weakness and is associated with a rash or polymyositis (PM) a disease that causes muscle weakness without a rashThis study will be done at approximately 37 centers across North America and Europe, including the University of Kentucky. Further information about the RIM trial can be found at: http://www.edc.gsph.pitt.edu/rimstudy/ UK Health Connections at 1-800-333-8874.
SCOT Study
SCOT is a clinical research study designed for people with severe forms of scleroderma. SCOT stands for Scleroderma: Cyclophosphamide Or Transplantation. The SCOT study will compare the potential benefits of stem cell transplant and high-dose monthly cyclophosphamide (Cytoxan) in the treatment of scleroderma. The study coordinator in charge of this study is Mary Johnson at 859 323 1377 or 1 800 929 2320. More information about the SCOT trial can be found at: http://www.sclerodermatrial.org/ UK Health Connections at 1-800-333-8874.
Inflammatory bowel disease (either Crohn's disease or ulcerative colitis)
Needed for mail-back research survey: people with inflammatory bowel disease (either Crohn's disease or ulcerative colitis) and their first degree relatives (mother, father, sister, brother, son or daughter).You may qualify if you are at least 14 years of age and are willing to commit 10 minutes to complete a mail-back survey. For more information please contact:Lisbeth Selby, M.D. at (859) 323-5575 or laselb0@uky.edu Chris Dunn, R.N. at 859 323-6423 or UK Health Connections at 1-800-333-8874.
